secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001193125-24-138316
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allogene Therapeutics raises $110M in registered equity offering at $2.90 per share with insider participation
--------------------------------------------------------------------------------

- Offering of 37,931,035 shares at $2.90 per share for gross proceeds of ~$110M; expected to close May 16, 2024.
- Insiders Arie Belldegrun, David Chang, and Geoffrey Parker each purchasing 344,828 shares in the offering.
- Goldman Sachs & Co. LLC acted as sole underwriter; offering made under effective shelf registration statement.
- Net proceeds after underwriting discounts and expenses will be used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000119312524138316/0001193125-24-138316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000119312524138316/d846176d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-138316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer